CH618170A5 - - Google Patents
Download PDFInfo
- Publication number
- CH618170A5 CH618170A5 CH9274A CH9274A CH618170A5 CH 618170 A5 CH618170 A5 CH 618170A5 CH 9274 A CH9274 A CH 9274A CH 9274 A CH9274 A CH 9274A CH 618170 A5 CH618170 A5 CH 618170A5
- Authority
- CH
- Switzerland
- Prior art keywords
- amino
- dihydro
- triazin
- methyl
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB55373*[A GB1457873A (en) | 1973-01-04 | 1973-01-04 | Imidazotriazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH618170A5 true CH618170A5 (pl) | 1980-07-15 |
Family
ID=9706420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH9274A CH618170A5 (pl) | 1973-01-04 | 1974-01-02 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US3941785A (pl) |
| JP (1) | JPS4995994A (pl) |
| AT (1) | AT336029B (pl) |
| AU (1) | AU474078B2 (pl) |
| BE (1) | BE809369A (pl) |
| CA (1) | CA1005057A (pl) |
| CH (1) | CH618170A5 (pl) |
| DE (1) | DE2364076A1 (pl) |
| ES (1) | ES422001A1 (pl) |
| FI (1) | FI57260C (pl) |
| FR (1) | FR2213058B1 (pl) |
| GB (1) | GB1457873A (pl) |
| IE (1) | IE38681B1 (pl) |
| IL (1) | IL43872A (pl) |
| LU (1) | LU69099A1 (pl) |
| NL (1) | NL7400095A (pl) |
| NO (1) | NO140301C (pl) |
| SE (1) | SE408179B (pl) |
| ZA (1) | ZA739534B (pl) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK109578A (da) * | 1977-03-25 | 1978-09-26 | Allen & Hanburys Ltd | Fremgangsmaade til fremstilling af heterocycliske forbindelser |
| US4096257A (en) * | 1977-05-23 | 1978-06-20 | American Cyanamid Company | Substituted imidazo [1,2-d]-as-triazines |
| US4107309A (en) * | 1977-05-23 | 1978-08-15 | American Cyanamid Company | Substituted imidazo[1,2-d]-as-triazines |
| US4126444A (en) * | 1977-11-22 | 1978-11-21 | American Cynamid Company | Substituted imidazo (1,5-D)-as-triazin-4-ols, and herbicidal use thereof |
| US4308384A (en) * | 1978-09-18 | 1981-12-29 | Glaxo Group Limited | Production of triazinones |
| DD244681A3 (de) * | 1985-12-02 | 1987-04-15 | Zeiss Jena Veb Carl | Vorrichtung zur positionierung von enden flexibler lichtleitelemente |
| US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
| PT1049695E (pt) * | 1997-11-12 | 2002-07-31 | Bayer Ag | Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase |
| DE19827640A1 (de) * | 1998-06-20 | 1999-12-23 | Bayer Ag | 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone |
| BR9913152A (pt) | 1998-08-26 | 2001-05-15 | Smithkline Beecham Corp | Terapias para tratamento de doenças pulmonares |
| KR100701904B1 (ko) * | 1999-08-21 | 2007-04-02 | 알타나 파마 아게 | Ｐｄｅ 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합 |
| PL363679A1 (pl) * | 2001-05-09 | 2004-11-29 | Bayer Healthcare Ag | Nowe zastosowanie 2-fenylo-podstawionych imidazotriazynonów |
| GB0113344D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel heterocycles 3 |
| GB0113343D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 2 |
| DE10130167A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Imidazotriazine |
| DE10135815A1 (de) | 2001-07-23 | 2003-02-06 | Bayer Ag | Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen |
| DE10230604A1 (de) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Heterocyclisch substituierte Imidazotriazine |
| DE10230605A1 (de) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Substituierte Imidazotriazine |
| DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| JP2006522127A (ja) * | 2003-04-01 | 2006-09-28 | スミスクライン ビーチャム コーポレーション | イミダゾトリアジン化合物 |
| DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
| DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
| DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| US20090186896A1 (en) * | 2005-09-29 | 2009-07-23 | Bayer Healthcare Ag | PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders |
| EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
| WO2007053596A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| AU2007223036A1 (en) * | 2006-03-08 | 2007-09-13 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| EP2026813A2 (en) * | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス，インコーポレイティド | アンジオテンシン調節による神経新生 |
| KR20090064418A (ko) * | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| CA2663347A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Ppar mediated modulation of neurogenesis |
| WO2008151734A1 (en) * | 2007-06-13 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | Pde inhibitors for the treatment of hearing impairment |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE791025A (fr) * | 1971-11-19 | 1973-05-07 | Allen & Hanburys Ltd | Composes heterocycliques |
-
1973
- 1973-01-04 GB GB55373*[A patent/GB1457873A/en not_active Expired
- 1973-12-18 FI FI3900/73A patent/FI57260C/fi active
- 1973-12-18 ZA ZA739534A patent/ZA739534B/xx unknown
- 1973-12-18 NO NO4843/73A patent/NO140301C/no unknown
- 1973-12-19 AU AU63774/73A patent/AU474078B2/en not_active Expired
- 1973-12-20 IL IL43872A patent/IL43872A/xx unknown
- 1973-12-21 DE DE2364076A patent/DE2364076A1/de not_active Withdrawn
- 1973-12-26 US US05/427,558 patent/US3941785A/en not_active Expired - Lifetime
- 1973-12-28 FR FR7346979A patent/FR2213058B1/fr not_active Expired
- 1973-12-28 CA CA189,199A patent/CA1005057A/en not_active Expired
- 1973-12-31 JP JP49004782A patent/JPS4995994A/ja active Pending
- 1973-12-31 IE IE2345/73A patent/IE38681B1/xx unknown
-
1974
- 1974-01-02 CH CH9274A patent/CH618170A5/de not_active IP Right Cessation
- 1974-01-02 AT AT2374A patent/AT336029B/de not_active IP Right Cessation
- 1974-01-02 LU LU69099A patent/LU69099A1/xx unknown
- 1974-01-03 SE SE7400062A patent/SE408179B/xx unknown
- 1974-01-03 BE BE139496A patent/BE809369A/xx unknown
- 1974-01-03 ES ES422001A patent/ES422001A1/es not_active Expired
- 1974-01-04 NL NL7400095A patent/NL7400095A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE38681L (en) | 1974-07-04 |
| IL43872A (en) | 1979-01-31 |
| NL7400095A (pl) | 1974-07-08 |
| JPS4995994A (pl) | 1974-09-11 |
| FI57260B (fi) | 1980-03-31 |
| IL43872A0 (en) | 1974-03-14 |
| AU6377473A (en) | 1975-06-19 |
| ATA2374A (de) | 1976-08-15 |
| ZA739534B (en) | 1974-11-27 |
| FI57260C (fi) | 1980-07-10 |
| GB1457873A (en) | 1976-12-08 |
| FR2213058A1 (pl) | 1974-08-02 |
| AT336029B (de) | 1977-04-12 |
| DE2364076A1 (de) | 1974-07-18 |
| NO140301B (no) | 1979-04-30 |
| NO140301C (no) | 1979-08-08 |
| ES422001A1 (es) | 1976-08-01 |
| CA1005057A (en) | 1977-02-08 |
| IE38681B1 (en) | 1978-05-10 |
| LU69099A1 (pl) | 1974-04-02 |
| AU474078B2 (en) | 1976-07-15 |
| SE408179B (sv) | 1979-05-21 |
| FR2213058B1 (pl) | 1977-07-01 |
| US3941785A (en) | 1976-03-02 |
| BE809369A (fr) | 1974-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH618170A5 (pl) | ||
| DE69918528T2 (de) | Bicyclische heteroaromatische verbindungen als protein tyrosine kinase inhibitoren | |
| DE1445151A1 (de) | Verfahren zur Herstellung chemischer Verbindungen | |
| DE1493955A1 (de) | Verfahren zur Herstellung substituierter Sulfonanilide | |
| US4201860A (en) | Purine derivatives | |
| EP0287907A1 (de) | Pyrazolo[3,4-d]pyrimidine, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel | |
| DE1670849B2 (de) | Verfahren zur herstellung von 8-acylamino-1,2,3,4-tetrahydroisochinolinen | |
| EP0165422B1 (de) | Neue substituierte Bis(4-aminophenyl)sulfone, ihre Herstellung und ihre Verwendung als Arzneimittel | |
| DE2918261C2 (pl) | ||
| DE1620694B2 (de) | Verfahren zur Herstellung von 5-Methyl-7-diäthylamino-s-triazolo [1,5-a] pyrimidin und seinen Salzen mit Säuren | |
| DE2505297B2 (de) | Verfahren zur Herstellung von in 2- und 6-Stellung des Phenylkerns substituierten 2-Phenylamino-2-imidazolin-Derivaten | |
| DE1770372A1 (de) | Neue Indolinderivate und Verfahren zu ihrer Herstellung | |
| CH626351A5 (pl) | ||
| DE3328636A1 (de) | Xanthinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| EP0271099A2 (de) | Substituierte Aminopropionsäureamide, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung sowie die bei der Herstellung anfallenden neuen Zwischenprodukte | |
| DE2526795A1 (de) | Sulfonamide | |
| DE3816634A1 (de) | Cyclobuten-3,4-dion-zwischenverbindungen, verfahren zu ihrer herstellung und ihre verwendung | |
| DE1620342C3 (pl) | ||
| DE2854341C2 (pl) | ||
| AT299202B (de) | Verfahren zur Herstellung von neuen substituierten Isochinolinen und von deren Säureadditionssalzen | |
| DE3245950A1 (de) | Verfahren zur herstellung substituierter pyridine | |
| DE2824291A1 (de) | Neue benzylalkoholderivate und verfahren zu ihrer herstellung | |
| DE2354327B2 (de) | 2-amino-1,2,3,4-tetrahydronaphthalin- derivate, verfahren zu deren herstellung und verfahren zur herstellung von 6,7- benzomorphanen ausgehend von jenen | |
| DE1493961A1 (de) | Verfahren zur Herstellung von substituierten 1-Hydroxy-2-alkylamino-1-phenylalkanen | |
| DE1620171A1 (de) | Verfahren zur Herstellung von heterocyclischen Verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |